Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma (Q45735099)

15 December 2017

Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma (English)

1 reference

15 December 2017

0 references

0 references

D Chua

1

1 reference

15 December 2017

J Huang

2

1 reference

15 December 2017

B Zheng

3

1 reference

15 December 2017

S Y Lau

4

1 reference

15 December 2017

W Luk

5

1 reference

15 December 2017

D L Kwong

6

1 reference

15 December 2017

J S Sham

7

1 reference

15 December 2017

D Moss

8

1 reference

15 December 2017

K Y Yuen

9

1 reference

15 December 2017

S W Im

10

1 reference

15 December 2017

M H Ng

11

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

International Journal of Cancer

15 December 2017

1 reference

15 December 2017

94

1 reference

15 December 2017

1

1 reference

15 December 2017

73-80

1 reference

Carcinoma of the nasopharynx. The significance of lymphocytic infiltration

15 December 2017

1 reference

Infiltrating lymphocytes and accessory cells in nasopharyngeal carcinoma.

21 January 2018

1 reference

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

21 January 2018

1 reference

Epstein-Barr virus persistence and virus-associated tumours

21 January 2018

1 reference

Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy.

21 January 2018

1 reference

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

21 January 2018

1 reference

Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients

21 January 2018

1 reference

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

21 January 2018

1 reference

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

Expression of epstein-barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients

21 January 2018

1 reference

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

21 January 2018

1 reference

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma

21 January 2018

1 reference

Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection.

21 January 2018

1 reference

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

21 January 2018

1 reference

The significance of keratinizing squamous cell histology in Chinese patients with nasopharyngeal carcinoma.

21 January 2018

1 reference

Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients.

21 January 2018

1 reference

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells

21 January 2018

1 reference

A new microcellular cytotoxicity test based on calcein AM release

21 January 2018

1 reference

Limiting dilution analysis of human T cells: a useful clinical tool

21 January 2018

1 reference

The evaluation of limiting dilution assays

21 January 2018

1 reference

Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection

21 January 2018

1 reference

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

21 January 2018

1 reference

Epstein-Barr virus latent infection in vivo

21 January 2018

1 reference

Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomas

21 January 2018

1 reference

Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus

21 January 2018

1 reference

Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1430

1 reference

release_yzmkmd7z3vcqzeyx4e2l6qgzcu

15 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yzmkmd7z3vcqzeyx4e2l6qgzcu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference